SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: robert heisman who wrote (7175)4/7/1998 8:00:00 PM
From: Chuca Marsh  Read Replies (1) | Respond to of 8116
 
So, if I say the same THING, it will shoot up soon? Chucxa



To: robert heisman who wrote (7175)4/7/1998 8:01:00 PM
From: ge  Read Replies (2) | Respond to of 8116
 
Look at the biotechs that have revenues of 10 million or more. One that I read about on the Yahoo board is BTGC. Revenues that look as if they mirror CYTO, 51 million shares out, no blockbuster drugs and the stock is selling at 9. Why? Because they make a profit. If CYTO would reduce costs so that they could see a profit, you are looking at a $9.00 stock. Look at the numbers for yourself. It can be done.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News